[go: up one dir, main page]

NO881151D0 - Syntetisk hiv-1-antigen. - Google Patents

Syntetisk hiv-1-antigen.

Info

Publication number
NO881151D0
NO881151D0 NO881151A NO881151A NO881151D0 NO 881151 D0 NO881151 D0 NO 881151D0 NO 881151 A NO881151 A NO 881151A NO 881151 A NO881151 A NO 881151A NO 881151 D0 NO881151 D0 NO 881151D0
Authority
NO
Norway
Prior art keywords
antigen
synthetic hiv
hiv
synthetic
Prior art date
Application number
NO881151A
Other languages
English (en)
Other versions
NO881151L (no
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Virovahl Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8701294A external-priority patent/SE468181B/sv
Application filed by Virovahl Sa filed Critical Virovahl Sa
Publication of NO881151D0 publication Critical patent/NO881151D0/no
Publication of NO881151L publication Critical patent/NO881151L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
NO881151A 1987-03-27 1988-03-16 Syntetisk hiv-1-antigen. NO881151L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8701294A SE468181B (sv) 1987-03-27 1987-03-27 Hiv-1 gp41 peptid, vaccin och antigen innehaallande peptiden jaemte diagnostiskt test med peptiden
US5172687A 1987-05-18 1987-05-18

Publications (2)

Publication Number Publication Date
NO881151D0 true NO881151D0 (no) 1988-03-16
NO881151L NO881151L (no) 1988-09-28

Family

ID=26659756

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881151A NO881151L (no) 1987-03-27 1988-03-16 Syntetisk hiv-1-antigen.

Country Status (9)

Country Link
EP (1) EP0284587A3 (no)
AU (1) AU606928B2 (no)
CA (1) CA1336473C (no)
DK (1) DK164088A (no)
ES (1) ES2013328A6 (no)
FI (1) FI881418L (no)
NO (1) NO881151L (no)
NZ (1) NZ224046A (no)
RU (1) RU1802871C (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
US5204259A (en) * 1988-05-06 1993-04-20 Pharmacia Genetic Engineering, Inc. Methods and systems for producing HIV antigens
DE68925660T2 (de) * 1988-06-10 1996-09-26 United Biomedical Inc Peptidfragmente von HIV
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Hiv構成蛋白に対するモノクローナル抗体
SE8900721D0 (sv) * 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
GB8918200D0 (en) * 1989-08-09 1989-09-20 Medical Res Council The peptide fragments of hiv
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
WO1991008227A1 (en) * 1989-11-27 1991-06-13 Replico Medical Aktiebolag NEW HIV-1 p17 PEPTIDES, DIAGNOSTIC ANTIGENS AND IMMUNOASSAY METHOD
EP0510054A1 (en) * 1990-01-05 1992-10-28 United Biomedical, Inc. Hiv-1 core protein fragments
US5427907A (en) * 1990-02-23 1995-06-27 Virginia Commonwealth University Assay for equine infectious anemia virus
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
EP0787191B2 (fr) 1994-10-20 2011-10-26 Institut Pasteur Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
FR2731225B1 (fr) * 1995-03-03 2003-10-31 Pasteur Institut Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
EP1131633A2 (en) 1998-11-16 2001-09-12 Board of Regents, The University of Texas System Hiv-specific t-cell induction
DE60233235D1 (de) 2001-09-04 2009-09-17 Wisconsin Alumni Res Found Flüssigkristallumschaltmechanismus
US7807348B2 (en) 2002-03-20 2010-10-05 Wisconsin Alumni Research Foundation Optical imaging of nanostructured substrates
US7125592B2 (en) 2002-04-10 2006-10-24 Wisconsin Alumni Research Foundation Detecting interactions at biomimetic interfaces with liquid crystals
US6849321B2 (en) 2002-11-08 2005-02-01 Wisconsin Alumni Research Foundation Surfaces with gradients in surface topography
US7303694B2 (en) 2003-07-17 2007-12-04 Wisconsin Alumni Research Foundation Liquid crystals with reduced toxicity and applications thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341620C (en) * 1984-10-18 2011-08-23 Luc Montagnier Envelope antigens of hiv-1
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
EP0220273B2 (en) * 1985-04-29 2007-01-17 Bio-Rad Laboratories, Inc. Synthetic antigens for the detection of aids-related disease
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
JPS63502904A (ja) * 1986-03-24 1988-10-27 オ−ソ・フア−マシユ−チカル・コ−ポレ−シヨン 合成htlv−3ペプチド、その組成物及び用途
EP0269712A4 (en) * 1986-06-12 1990-06-26 Biogen Nv PEPTIDES INVOLVED IN THE PATHOGENESIS OF A HIV TYPE INFECTION.

Also Published As

Publication number Publication date
RU1802871C (ru) 1993-03-15
AU1380788A (en) 1988-09-29
AU606928B2 (en) 1991-02-21
NO881151L (no) 1988-09-28
FI881418L (fi) 1988-09-28
DK164088D0 (da) 1988-03-25
DK164088A (da) 1988-09-28
CA1336473C (en) 1995-07-25
FI881418A0 (fi) 1988-03-24
NZ224046A (en) 1990-07-26
EP0284587A3 (en) 1990-11-22
ES2013328A6 (es) 1990-05-01
EP0284587A2 (en) 1988-09-28

Similar Documents

Publication Publication Date Title
NO881151D0 (no) Syntetisk hiv-1-antigen.
NO880395D0 (no) Antigener.
DE3883899D1 (de) Geänderte antikörper.
NO883395L (no) Mikrobicid mikroemulsjon.
FI902142A0 (fi) Sorteringstransportoer.
DE3862564D1 (de) Erdanker.
DE3879452D1 (de) Chimaere antikoerper.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
IT8821018A0 (it) Proietto.
DE3876873D1 (de) Weblitzenuebergabevorrichtung.
DE3785663D1 (de) Loetgeraet.
FI901765A0 (fi) Syntetisk gen.
FI901763A0 (fi) Syntetisk gen.
DE3877421D1 (de) Polyamidbenzazole.
DE3879348D1 (de) Fm-cw-radargeraet.
FI880167A0 (fi) Kemisk aotervinningsprocess.
DE3878970D1 (de) Praeparative chromatographiesaeule.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
DE3861694D1 (de) Cyclopropancarboxamide.
FI883435A0 (fi) Styrsystem foer fluider under tryck.
DE3860307D1 (de) 2-aminomethyltetrahydrofurane.
DE3860710D1 (de) Exklusiv-oder-schaltung.
DE3866770D1 (de) Gerbstoff.
DE3867805D1 (de) Paraocclusaler loeffel.
DE3879625D1 (de) Laseroszillator.